Table 1.
Baseline characteristics of AEG patients
| Characteristics | AEG patients (n=31) |
|---|---|
| Age (years) | |
| Median | 61 |
| Range | 46-70 |
| Gender, No. (%) | |
| Male | 26 (83.9) |
| Female | 5 (16.1) |
| ECOG score, No. (%) | |
| 0 | 8 (25.8) |
| 1 | 23 (74.2) |
| Siewert’s type, No. (%) | |
| II | 21 (67.7) |
| III | 10 (32.3) |
| Vertical axis diameter of the tumor (cm) | |
| Median | 6 |
| Range | 4-8 |
| Lauren type, No. (%) | |
| Intestinal | 20 (64.5) |
| Diffuse | 11 (35.5) |
| HER2 status, No. (%) | |
| 0 | 8 (25.8) |
| 1+ | 16 (51.6) |
| 2+ and Fish(-) | 7 (22.6) |
| Clinical T stage, No. (%) | |
| cT3 | 2 (6.5) |
| cT4 | 29 (93.5) |
| Clinical N stage, No. (%) | |
| cN1 | 13 (41.9) |
| cN2 | 12 (38.7) |
| cN3 | 6 (19.4) |
| Clinical TNM stage III, No. (%) | 31 (100.0) |
AEG, adenocarcinoma of the esophagogastric junction; ECOG, Eastern Cooperative Oncology Group; HER2, human epidermal growth factor receptor 2.